Company Filing History:
Years Active: 1984
Title: The Innovative Contributions of Carl-Gustaf M. Magnusson
Introduction: Carl-Gustaf M. Magnusson, based in Brussels, Belgium, is a notable inventor recognized for his significant contributions to the field of immunology. With a focus on improving immunoassays, he has demonstrated an impressive capacity for innovation, leading to advancements in the accuracy and sensitivity of protein assays.
Latest Patents: Magnusson holds a patent for an immunoassay of proteins that addresses the challenges presented by interference from other proteins in biological fluids. His invention outlines a method wherein biological fluids can be subjected to protein digestion, utilizing enzymes such as pepsin. This process minimizes interference in assays, allowing for precise measurements of the target proteins of interest. Additionally, his technique enhances the sensitivity and accuracy of radioallergosorbent tests for specific IgE antibodies by digesting absorbed IgE and subsequently assaying the fragments.
Career Highlights: Carl-Gustaf M. Magnusson is affiliated with the International Institute of Cellular and Molecular Pathology, where he actively contributes to research and development within the realm of cellular biology and immunology. His dedication to scientific progress is evident through his pioneering work in developing methods that foster more reliable diagnostic practices.
Collaborations: Throughout his career, Magnusson has collaborated with esteemed colleagues, including Daniel Collet-Cassart and Pierre L. Masson. These partnerships have further enriched his research endeavors and have been instrumental in advancing the fields they collectively work in.
Conclusion: Carl-Gustaf M. Magnusson is an inventor whose work has made a significant impact on immunoassay methodologies. His pioneering patent on reducing interference from other proteins illustrates the importance of innovation in the realm of biological research. As he continues his work with the International Institute of Cellular and Molecular Pathology, his contributions will undoubtedly lead to further advancements in the medical and scientific communities.